Literature DB >> 16211868

Peptide vaccines against cancer.

Jay A Berzofsky1, Sangkon Oh, Masaki Terabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16211868     DOI： 10.1007/0-387-27545-2_5

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  4 in total

1.  HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Authors:  Brian M Olson; Thomas P Frye; Laura E Johnson; Lawrence Fong; Keith L Knutson; Mary L Disis; Douglas G McNeel
Journal:  Cancer Immunol Immunother       Date:  2010-02-06       Impact factor: 6.968

2.  Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.

Authors:  Saied Mirshahidi; Victor G Kramer; James B Whitney; Sosthène Essono; Sandra Lee; Glenn Dranoff; Karen S Anderson; Ruth M Ruprecht
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

3.  Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.

Authors:  Yi-Hsiang Huang; Masaki Terabe; C David Pendleton; Deborah Stewart Khursigara; Tapan K Bera; Ira Pastan; Jay A Berzofsky
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

4.  Induction of humoral immune responses and inhibition of metastasis in mice by a VEGF peptide-based vaccine.

Authors:  Faezeh Soltanpour Gharibdousti; Banafsheh Fazeli Delshad; Reza Falak; Nasrin Shayanfar; Mazdak Ganjalikhani Hakemi; Alireza Andalib; Gholam Ali Kardar
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.